Target intelligence / Profile preview

XK-related protein 4 (XKR4)

Target
XKR4
Molecular classification
Scramblase (phospholipid scramblase), Transmembrane protein, Other (X-Kell related protein family)
01

Overview

XK-related protein 4 (XKR4) is a member of the X-Kell related (Xkr) protein family and functions as a **phospholipid scramblase** that catalyzes the bidirectional movement (“scrambling”) of phosphatidylserine across the plasma membrane, a process critical for the recognition and clearance of apoptotic cells. Activation involves structural changes—often mediated by caspase cleavage, dimerization, binding of the XRCC4 protein fragment, and crucially, extracellular calcium coordination between transmembrane helices—which exposes phosphatidylserine as an “eat me” signal[1]. However, recent research demonstrates that purified, full-length human XKR4 functions as a monomeric scramblase without absolute dependence on caspase processing or oligomerization, suggesting intrinsic scrambling activity[2][3]. The protein consists of ten transmembrane helices and contains an electronegative vestibule thought to induce membrane thinning, facilitating lipid translocation. Defective XKR4 function impairs dead cell clearance, leading to inflammation; however, no direct pharmacological modulators or disease-targeted therapies have been reported. XKR4 is structurally and mechanistically related to XKR8 and XKR9, but remains distinct in its regulatory requirements and monomeric activity[1][2].

Other names
KIAA1889XRG4hXKR4XK-related protein 4, processed formXK Kell blood group precursor-related family, member 4X-linked Kx blood group related 4Kell blood group complex subunit-related family, member 4
02

Mechanism of action

Not applicable (no drugs directly targeting XKR4 documented)

03

Biological functions

Phospholipid scrambling (externalization of phosphatidylserine)Apoptosis (enables “eat me” signal for dying cell recognition)Cell death
04

Disease associations

Inflammation (defective Xkr4 linked to impaired clearance of dying cells and subsequent inflammation)[3]Other (potential implications in disorders of cell clearance; no direct links to cancer, neurodegenerative, or infectious diseases reported in sources)
05

Safety considerations

Therapeutic targeting might risk disrupting apoptotic cell clearance leading to inflammation or autoimmunity[3]Notable challenges include lack of specific drug modulators[2]
06

Biomarkers

Externalized phosphatidylserine (indicative of activation of scramblases like XKR4)XKR4 expression/activity (potentially as a research biomarker in apoptosis or inflammation)[3]

Beyond the preview

Go deeper on XK-related protein 4 (XKR4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XK-related protein 4 (XKR4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call